Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|May 19, 2006
HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanismKotha Subbaramaiah, Louise R Howe, Elisa R Port, et al.Annals of Surgical Oncology|April 22, 2009
Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodesAmer K Karam, Meier Hsu, Sujata Patil, et al.Nature Communications|August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant diseaseKatsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)William M Sikov, Donald A Berry, Charles M Perou, et al.Nature|December 13, 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheRosandra N Kaplan, Rebecca D Riba, Stergios Zacharoulis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerJonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.Pageof 2